2015 annual financial data
Regencell Bioscience 2015 Operating margin
Regencell Bioscience 2015 operating margin with verified reported values.
Direct answer
Operating margin was 10.25%.
Operating income was 306,400,000 USD and net income was 105,600,000 USD.
Operating cash flow was 349,100,000 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,990,100,000 USD
- Operating income
- 306,400,000 USD
- Net income
- 105,600,000 USD
- Operating cash flow
- 349,100,000 USD